401 related articles for article (PubMed ID: 8574812)
1. Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits.
Acheampong AA; Breau A; Shackleton M; Luo W; Lam S; Tang-Liu DD
J Ocul Pharmacol Ther; 1995; 11(4):489-502. PubMed ID: 8574812
[TBL] [Abstract][Full Text] [Related]
2. Disposition of levobunolol after an ophthalmic dose to rabbits.
Tang-Liu DD; Liu S; Neff J; Sandri R
J Pharm Sci; 1987 Oct; 76(10):780-3. PubMed ID: 3323465
[TBL] [Abstract][Full Text] [Related]
3. Ocular metabolism of levobunolol.
Tang-Liu DD; Shackleton M; Richman JB
J Ocul Pharmacol; 1988; 4(3):269-78. PubMed ID: 3058836
[TBL] [Abstract][Full Text] [Related]
4. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits.
Burgalassi S; Chetoni P; Panichi L; Boldrini E; Saettone MF
J Ocul Pharmacol Ther; 2000 Dec; 16(6):497-509. PubMed ID: 11132897
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
Phan TM; Nguyen KP; Giacomini JC; Lee DA
J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of aqueous humor concentrations of Istalol and Betimol following a single ocular instillation in rabbit eyes.
Baklayan GA; Collins EC; Thetford T; Soriano A; Song CK; Han J
J Ocul Pharmacol Ther; 2008 Oct; 24(5):507-12. PubMed ID: 18800867
[TBL] [Abstract][Full Text] [Related]
7. Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing.
Tan AY; LeVatte TL; Archibald ML; Tremblay F; Kelly ME; Chauhan BC
J Glaucoma; 2002 Apr; 11(2):134-42. PubMed ID: 11912361
[TBL] [Abstract][Full Text] [Related]
8. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
Okabe K; Kimura H; Okabe J; Ogura Y
Retina; 2007; 27(6):770-7. PubMed ID: 17621189
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
Chiang CH; Ho JI; Chen JL
J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
[TBL] [Abstract][Full Text] [Related]
10. The Relationship of Brimonidine Concentration in Vitreous Body to the Free Concentration in Retina/Choroid Following Topical Administration in Pigmented Rabbits.
Shinno K; Kurokawa K; Kozai S; Kawamura A; Inada K; Tokushige H
Curr Eye Res; 2017 May; 42(5):748-753. PubMed ID: 27854122
[TBL] [Abstract][Full Text] [Related]
11. Ocular distribution of digoxin-3H in the cat.
Lufkin MW; Harrison CE; Henderson JW; Ogle KN
Am J Ophthalmol; 1967 Dec; 64(6):1134-40. PubMed ID: 6072988
[No Abstract] [Full Text] [Related]
12. Bioavailability of timolol and aceclidine after ocular instillation in the rabbit.
Matera MG; Lampa E; Imperatore A; Berrino L; Russo F; Boldrini E; Rossi F
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):35-42. PubMed ID: 9644717
[TBL] [Abstract][Full Text] [Related]
13. The ocular distribution of bunolol in the eyes of albino and pigmented rabbits.
Chen CC; Koda RT; Shackleton M
J Ocul Pharmacol; 1988; 4(1):37-42. PubMed ID: 3049859
[TBL] [Abstract][Full Text] [Related]
14. Binding of the beta-blockers timolol and H 216/44 to ocular melanin.
Abrahamsson T; Boström S; Bräutigam J; Lagerström PO; Regårdh CG; Vauqelin G
Exp Eye Res; 1988 Oct; 47(4):565-77. PubMed ID: 2903066
[TBL] [Abstract][Full Text] [Related]
15. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
Kyyrönen K; Urtti A
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
[TBL] [Abstract][Full Text] [Related]
16. Application site dependent ocular absorption of timolol.
Urtti A; Sendo T; Pipkin JD; Rork G; Repta AJ
J Ocul Pharmacol; 1988; 4(4):335-43. PubMed ID: 3246568
[TBL] [Abstract][Full Text] [Related]
17. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
Lee YH; Kompella UB; Lee VH
Exp Eye Res; 1993 Sep; 57(3):341-9. PubMed ID: 7901046
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administration.
Holló G; Whitson JT; Faulkner R; McCue B; Curtis M; Wieland H; Chastain J; Sanders M; DeSantis L; Przydryga J; Dahlin DC
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):235-40. PubMed ID: 16384968
[TBL] [Abstract][Full Text] [Related]
19. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
[TBL] [Abstract][Full Text] [Related]
20. Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
Biol Pharm Bull; 2008 Aug; 31(8):1590-5. PubMed ID: 18670094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
